Profil
Yueh Hsin Lai is currently a Director-Supervisory Board at CytoPharm, Inc. and a Director at Tai Hsin Venture Capital Co., Ltd., Fu Yung Biotechnology Co. Ltd., and Fu Yung Investment Co. Ltd.
Previously, Lai was a Director at EPS Bio Technology Corp.
Aktive Positionen von Yueh Hsin Lai
| Unternehmen | Position | Beginn |
|---|---|---|
CytoPharm, Inc.
 CytoPharm, Inc. Pharmaceuticals: MajorHealth Technology CytoPharm, Inc. engages in the biopharmaceutical industry. The company specializes in protein drug development. It focuses on producing human natural cytokines such as interferon, interleukin and chemokine as modulators of human immune system. The products can be utilized in single or cocktail treatment model for chronic virus hepatitis, various oncology diseases, virus infection and autoimmune diseases. The company was founded on February 12, 2003 and is headquartered in Taipei, Taiwan. | Direktor/Vorstandsmitglied | 22.09.2011 |
| Fu Yung Biotechnology Co. Ltd. | Direktor/Vorstandsmitglied | 22.09.2011 |
| Fu Yung Investment Co. Ltd. | Direktor/Vorstandsmitglied | 22.09.2011 |
| Tai Hsin Venture Capital Co., Ltd. /Taiwan/ | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Yueh Hsin Lai
| Unternehmen | Position | Ende |
|---|---|---|
| EPS BIO TECHNOLOGY CORP. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| EPS BIO TECHNOLOGY CORP. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
CytoPharm, Inc.
CytoPharm, Inc. Pharmaceuticals: MajorHealth Technology CytoPharm, Inc. engages in the biopharmaceutical industry. The company specializes in protein drug development. It focuses on producing human natural cytokines such as interferon, interleukin and chemokine as modulators of human immune system. The products can be utilized in single or cocktail treatment model for chronic virus hepatitis, various oncology diseases, virus infection and autoimmune diseases. The company was founded on February 12, 2003 and is headquartered in Taipei, Taiwan. | Health Technology |
| Fu Yung Biotechnology Co. Ltd. | |
| Fu Yung Investment Co. Ltd. | |
| Tai Hsin Venture Capital Co., Ltd. /Taiwan/ |
